Judith Ochs

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission

A. John Barrett, Mary M. Horowitz, Brad H. Pollock et al. · New England Journal of Medicine · 1994 · 236 citations · Full text

Intensive Retreatment of Childhood Acute Lymphoblastic Leukemia in First Bone Marrow Relapse

Gaston K. Rivera, George R. Buchanan, James M. Boyett et al. · New England Journal of Medicine · 1986 · 148 citations

Hematological Malignancy, Oncology, Pediatric Hematology +15

Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis

June S. Taylor, J. William Langston, Wilburn E. Reddick et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 138 citations

Clinical Value, Brain Lesion, Glioma +16

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · 2017 · 97 citations

Medicine, Cancer Management, Symptomatic Patients +14